-
Drug-induced deaths in Europe (EMCDDA 2023 Statistical Bulletin)
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with...
HTML
Visualizza questo set di dati con Trends in drug-induced deaths in the European Union, Norway and Türkiye , Age distribution of drug-induced deaths reported in the European Union, Norway and Türkiye in 2021 (percent)
-
Drug-related infectious diseases in Europe (EMCDDA 2023 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML
Visualizza questo set di dati con Interactive map. Most-recent HIV outbreaks in Europe among people who inject drugs , New HIV notifications linked to injecting drug use in the European Union, 2009 to 2021 , Infographic. Drug-related infectious diseases
-
Health and social responses to drug problems in Europe (EMCDDA 2023 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML
Visualizza questo set di dati con Infographic. Coverage of opioid agonist treatment in 2021 or the most recent year and in the previous estimate , Infographic. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets , Infographic. Number of European countries implementing opioid agonist treatment, up to 2022 , Infographic. Clients in opioid agonist treatment
-
Problem drug use in Europe (EMCDDA 2023 Statistical Bulletin)
‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular...
HTML
Visualizza questo set di dati con Estimated number and prevalence of people who inject drugs, by country, 2015 to 2021
-
Drug treatment demand in Europe (EMCDDA 2023 Statistical Bulletin)
Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and...
HTML
Visualizza questo set di dati con Infographic. Cannabis users entering treatment in Europe , Infographic. Methamphetamine users entering treatment in Europe , Infographic. Amphetamine users entering treatment for in Europe , Infographic. Cocaine users entering treatment in Europe , Trends in injecting among first-time treatment entrants with heroin, cocaine, amphetamine or methamphetamine as primary drug: proportion reporting injecting as main route of administration , Infographic. Synthetic cathinone users entering treatment in Europe
-
Prevalence of drug use in Europe (EMCDDA 2023 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML
Visualizza questo set di dati con Dashboard. Prevalence of cannabis use in Europe , Dashboard. Prevalence of MDMA use in Europe , Dashboard. Prevalence of cocaine use in Europe , Dashboard. Prevalence of amphetamines use in Europe
-
Drug-related infectious diseases in Europe (EMCDDA 2022 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML
-
Health and social responses to drug problems in Europe (EMCDDA 2022 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML
-
Problem drug use in Europe (EMCDDA 2022 Statistical Bulletin)
‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular...
HTML
-
Prevalence of drug use in Europe (EMCDDA 2022 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML
-
Drug treatment demand in Europe (EMCDDA 2022 Statistical Bulletin)
Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and...
HTML
-
Drug treatment demand in Europe (EMCDDA 2020 Statistical Bulletin)
Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and...
HTML (48 visualizzazioni) (7 Download)
-
Prevalence of drug use in Europe (EMCDDA 2020 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML (50 visualizzazioni) (13 Download)
-
Health and social responses to drug problems in Europe (EMCDDA 2020 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML (54 visualizzazioni) (3 Download)
-
Drug overdose deaths in Europe (EMCDDA 2020 Statistical Bulletin)
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with...
HTML (66 visualizzazioni) (21 Download)
-
Drug-related infectious diseases in Europe (EMCDDA 2020 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML (106 visualizzazioni) (21 Download)
-
Problem drug use in Europe (EMCDDA 2020 Statistical Bulletin)
‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular...
HTML (182 visualizzazioni) (58 Download)
-
Drug-related infectious diseases in Europe (EMCDDA 2019 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML (190 visualizzazioni) (155 Download)
-
Health and social responses to drug problems in Europe (EMCDDA 2019 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML (248 visualizzazioni) (206 Download)
-
Prevalence of drug use in Europe (EMCDDA 2019 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML (250 visualizzazioni) (227 Download)